Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the prescription drugs market size evolved in recent years?

The market size of prescription medications has seen significant expansion lately. This market will escalate from a value of $1289.77 billion in 2024 to $1430.3 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.9%. The growth experienced in the historical period is a result of factors such as the increasing number of clinical trials, greater accessibility of over-the-counter (OTC) products, a surge in the necessity for daily prescriptions, escalating healthcare costs, and a rise in the occurrence of various chronic diseases.

What are the predictions for the prescription drugs market size in the coming years?

In the coming years, the prescription drug market is projected to experience substantial growth, expected to reach $2145.22 billion in 2029 with a compound annual growth rate of 10.7%. The growth anticipated in the market during the forecast period can be credited to factors including the surge in clinical trials, improved accessibility of over the counter (OTC) products, the increasing requirement for daily prescriptions, escalating healthcare expenditure, and the growing occurrence of chronic diseases. Key trends during this forecast period encompass the growing demand for biologic drugs, advancements in genomics and data analytics, heightened awareness about mental health disorders, the broadening scope of digital health, and the transition towards preventive medicine.

Get your prescription drugs market report here!

https://www.thebusinessresearchcompany.com/report/prescription-drugs-global-market-report

What key factors are fueling the growth of the prescription drugs market?

The growth of the prescription drug market is anticipated to be driven by the escalation in drug production. The comprehensive procedure of manufacturing pharmaceutical products – including formulating, testing, and packaging to ensure their quality, safety, and efficiency – constitutes drug production. The crucialness of upscaling drug production is underscored by the need to fulfill the escalating global requirement for medications, tackle public health issues, and facilitate the timely provision of treatments for varied health conditions. Enhancement in drug production can augment the accessibility, affordability, and innovation in the prescription drug market. This ultimately proves advantageous for patients and the healthcare system as it improves the procurement of indispensable medications and propels superior health outcomes. For instance, in June 2023, as per the European Federation of Pharmaceutical Industries and Associations (EFPIA) – a Belgium-based institution endorsing the pharmaceutical sector, the European pharmaceutical industry witnessed considerable growth in production, surging from a market value of $352.48 billion in 2021 to $369.95 billion in 2022. Hence, the growth of the prescription drug market is contingent on the rise in drug production.

How is the global prescription drugs market divided into key segments?

The prescription drugs market covered in this report is segmented –

1) By Type: Branded, Generics

2) By Route Of Administration: Oral, Topical, Parenteral, Other Routes Of Administration

3) By Therapy Area: Oncology, Immunology, Ophthalmology, Respiratory, Dermatology, Gastroenterology, Urology, Gynecology, Endocrinology, Other Therapy Areas

4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Branded: Innovative Drugs, Patented Drugs, Blockbuster Drugs, Over-the-Counter (OTC) Prescription Drugs, Biosimilars, Specialty Drugs, Orphan Drugs, Combination Drugs

2) By Generics: Small Molecule Generics, Generic Biologics, Over-the-Counter (OTC) Generics, Authorized Generics, Generic Combination Drugs, High-Volume Generics, Generic Versions Of Blockbuster Drugs

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20597&type=smp

Who are the key firms paving the way for growth in the prescription drugs market?

Major companies operating in the prescription drugs market are Pfizer Inc., Johnson & Johnson Private Limited, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Allergan plc, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Gilead Sciences Inc, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited

Which trends are expected to transform the prescription drugs market?

Leading corporations in the prescription medication industry are working on creating alternatives to Victoza (liraglutide), or similar GLP-1 receptor agonist treatments, to broaden the choice for managing type 2 diabetes. Victoza is a trademarked prescription drug that consists of liraglutide, a hormone similar to glucagon (GLP-1), and is primarily used to regulate type 2 diabetes in adults as well as in children who are 10 years or older. To illustrate, Teva Announces, a firm based in Israel, in June 2024, launched an authorized generic version of Victoza (liraglutide injection 1.8mg). This offers a cheaper option with the same formula, effectiveness, and quality as the original branded product. The introduction of this cheaper alternative aims to facilitate better access to crucial diabetes treatments, offering more financially viable methods for managing type 2 diabetes effectively and decreasing cardiovascular risks related to the disease.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20597

What regions are contributing significantly to the growth of the prescription drugs market?

North America was the largest region in the prescription drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prescription drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Pancreatic Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

Breast Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report

Lung Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: